Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$2.88 - $8.8 $32,544 - $99,440
11,300 Added 19.48%
69,314 $233,000
Q2 2023

Aug 09, 2023

SELL
$7.46 - $10.67 $71,616 - $102,432
-9,600 Reduced 14.2%
58,014 $480,000
Q1 2023

May 10, 2023

BUY
$8.44 - $13.35 $570,662 - $902,646
67,614 New
67,614 $590,000
Q2 2022

Aug 09, 2022

SELL
$6.61 - $11.99 $185,080 - $335,720
-28,000 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$11.56 - $17.9 $21,964 - $34,010
1,900 Added 7.28%
28,000 $324,000
Q4 2021

Feb 08, 2022

BUY
$17.36 - $27.36 $453,096 - $714,096
26,100 New
26,100 $459,000

Others Institutions Holding SGHT

About Sight Sciences, Inc.


  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $297M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.